Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
12.71
-0.13 (-1.01%)
At close: Apr 28, 2026, 4:00 PM EDT
12.66
-0.05 (-0.39%)
After-hours: Apr 28, 2026, 5:37 PM EDT
TNXP Employees
Tonix Pharmaceuticals Holding had 142 employees as of December 31, 2025. The number of employees increased by 61 or 75.31% compared to the previous year.
Employees
142
Change (1Y)
61
Growth (1Y)
75.31%
Revenue / Employee
$92,303
Profits / Employee
-$873,387
Market Cap
180.55M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| Cartesian Therapeutics | 75 |
| Precision BioSciences | 68 |
| Acumen Pharmaceuticals | 61 |
| Korro Bio | 58 |
| Corbus Pharmaceuticals Holdings | 36 |
| Whitehawk Therapeutics | 23 |
| Unicycive Therapeutics | 22 |
TNXP News
- 5 days ago - Tonix Pharmaceuticals Presents Updates on Preclinical Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2026 - GlobeNewsWire
- 13 days ago - Tonix Pharmaceuticals Announces Publication of Steady-State Pharmacokinetics of TONMYA® After 20 Days of Daily Dosing in the Peer-Reviewed Journal, Clinical Pharmacology in Drug Development - GlobeNewsWire
- 4 weeks ago - Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026 - GlobeNewsWire
- 4 weeks ago - Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain - GlobeNewsWire
- 5 weeks ago - Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026 - GlobeNewsWire
- 5 weeks ago - Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026 - GlobeNewsWire
- 6 weeks ago - Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026 - GlobeNewsWire
- 6 weeks ago - Tonix Pharmaceuticals Says Prescriptions For Chronic Pain Drug Top 4,200 Since Launch - Benzinga